IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
作者： YOSHIKO OKITA , YOSHITAKA NARITA , YASUJI MIYAKITA , MAKOTO OHNO , YUKO MATSUSHITA
关键词:
摘要: … and OS of the patients with a … OS of the patients who were initially treated with radiotherapy after surgery (n=16) were 2.9 and 4.2 years, respectively, and the PFS and OS of the patients …
sci-hub.se 参考文章(32)
E. G. Shaw, M. Wang, S. Coons, D. Brachman, J. C. Buckner, K. Stelzer, G. Barger, P. D. Brown, M. R. Gilbert, M. P. Mehta, Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG) Journal of Clinical Oncology. ,vol. 26, pp. 2006- 2006 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.2006
S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.-L. Guan, Y. Xiong, Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α Science. ,vol. 324, pp. 261- 265 ,(2009) , 10.1126/SCIENCE.1170944
Justin S Smith, Benjamin Alderete, Yuriko Minn, Thomas J Borell, Arie Perry, Gayatry Mohapatra, Sandra M Hosek, David Kimmel, Judith O'Fallon, Allan Yates, Burt G Feuerstein, Peter C Burger, Bernd W Scheithauer, Robert B Jenkins, Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene. ,vol. 18, pp. 4144- 4152 ,(1999) , 10.1038/SJ.ONC.1202759
Glenn Bauman, Barbara Fisher, Christopher Watling, J. Gregory Cairncross, David Macdonald, Adult supratentorial low-grade glioma: long-term experience at a single institution. International Journal of Radiation Oncology Biology Physics. ,vol. 75, pp. 1401- 1407 ,(2009) , 10.1016/J.IJROBP.2009.01.010
Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, J. ChulMin Kim, David N. Louis, Catherine L. Nutt, Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis Acta Neuropathologica. ,vol. 119, pp. 509- 511 ,(2010) , 10.1007/S00401-009-0632-Y
Thomas B. Daniels, Paul D. Brown, Sara J. Felten, Wenting Wu, Jan C. Buckner, Robert M. Arusell, Walter J. Curran, Ross A. Abrams, David Schiff, Edward G. Shaw, Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51 International Journal of Radiation Oncology*Biology*Physics. ,vol. 81, pp. 218- 224 ,(2011) , 10.1016/J.IJROBP.2010.05.003
Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito, Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients Cancer Science. ,vol. 103, pp. 587- 592 ,(2012) , 10.1111/J.1349-7006.2011.02175.X
Young-Ho Kim, Sumihito Nobusawa, Michel Mittelbronn, Werner Paulus, Benjamin Brokinkel, Kathy Keyvani, Ulrich Sure, Karsten Wrede, Yoichi Nakazato, Yuko Tanaka, Anne Vital, Luigi Mariani, Robert Stawski, Takuya Watanabe, Umberto De Girolami, Paul Kleihues, Hiroko Ohgaki, Molecular classification of low-grade diffuse gliomas. American Journal of Pathology. ,vol. 177, pp. 2708- 2714 ,(2010) , 10.2353/AJPATH.2010.100680
D. Schiff, P. D. Brown, C. Giannini, Outcome in adult low-grade glioma: the impact of prognostic factors and treatment Neurology. ,vol. 69, pp. 1366- 1373 ,(2007) , 10.1212/01.WNL.0000277271.47601.A1
Philippe Metellus, Bema Coulibaly, Carole Colin, Andre Maues de Paula, Alexandre Vasiljevic, David Taieb, Anne Barlier, Blandine Boisselier, Karima Mokhtari, Xiao Wei Wang, Anderson Loundou, Frederique Chapon, Sandrine Pineau, L’Houcine Ouafik, Olivier Chinot, Dominique Figarella-Branger, Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathologica. ,vol. 120, pp. 719- 729 ,(2010) , 10.1007/S00401-010-0777-8